+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The antimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malaria

The antimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malaria

Journal of Inorganic Biochemistry 47(3/4): 267-277

The antimalarial effects of 3-hydroxypyridin-4-ones (CP compounds), a family of bidentate orally effective iron chelators, were explored in experimental animal systems to assess the efficacy of deferoxamine (DF) against human Plasmodium falciparum malaria.

Accession: 002709841

Download citation: RISBibTeXText

PMID: 1431886

DOI: 10.1016/0162-0134(92)84072-u

Download PDF Full Text: The antimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malaria

Related references

The treatment of animal models of malaria with iron chelators by use of a novel polymeric device for slow drug release. Journal of Pharmacology and Experimental Therapeutics 281(3): 1127-1135, 1997

Iron chelators as antimalarial agents: in vitro activity of dicatecholate against Plasmodium falciparum. Journal of Antimicrobial ChemoTherapy 50(2): 177-187, 2002

The biochemical basis for the selective antimalarial action of iron chelators on Plasmodium falciparum parasitized cells. Advances in Experimental Medicine and Biology 356: 385-397, 1994

Effects of hydroxypyridinone iron chelators in combination with antimalarial drugs on the in vitro growth of Plasmodium falciparum. Southeast Asian Journal of Tropical Medicine and Public Health 32(1): 64-69, 2001

Antimalarial activity of selected aromatic chelators v localization of iron 59 in plasmodium falciparum in the presence of oxines. Eaton, J W , S R Meshnick And G J Brewer Progress in Clinical And Biological Research, Vol 313 Malaria And The Red Cell; 2nd Workshop, Ann Arbor, Michigan, Usa, October 24, 1988 Xi+169p Alan R Liss, Inc : New York, New York, Usa Illus 119-150, 1989

Antimalarial effect of iron chelators. Advances in Experimental Medicine and Biology 509: 251-272, 2003

Antimalarial effect of HBED and other phenolic and catecholic iron chelators. Blood 74(6): 2166-2171, 1989

The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators. Blood 77(3): 637-643, 1991

Clinical studies of iron chelators in malaria. Acta Haematologica 95(1): 78-86, 1996

Plasmodium falciparum: effect of antimalarial drugs, malaria pigment (β-haematin) and Plasmodium falciparum lysate on monocyte GTP-cyclohydrolase 1 gene expression. Experimental Parasitology 129(3): 312-317, 2011

Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 89(6): 672-676, 1995

Antimalarial iron chelator, FBS0701, shows asexual and gametocyte Plasmodium falciparum activity and single oral dose cure in a murine malaria model. Plos One 7(5): E37171-E37171, 2012

Severity of imported falciparum malaria: effect of taking antimalarial prophylaxis. Bmj 305(6856): 741-743, 1992

In vitro metabolism of ferroquine (SSR97193) in animal and human hepatic models and antimalarial activity of major metabolites on Plasmodium falciparum. Drug Metabolism and Disposition: the Biological Fate of Chemicals 34(4): 667-682, 2006